<SEC-DOCUMENT>0001193125-24-070191.txt : 20240318
<SEC-HEADER>0001193125-24-070191.hdr.sgml : 20240318
<ACCEPTANCE-DATETIME>20240318163102
ACCESSION NUMBER:		0001193125-24-070191
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240312
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240318
DATE AS OF CHANGE:		20240318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akero Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001744659
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38944
		FILM NUMBER:		24759497

	BUSINESS ADDRESS:	
		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-487-6488

	MAIL ADDRESS:	
		STREET 1:		601 GATEWAY BOULEVARD, SUITE 350
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d691064d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:akro="http://www.akerotx.com/20240312" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-270">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-03-12_to_2024-03-12">0001744659</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="akro-20240312.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-03-12_to_2024-03-12"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001744659</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-03-12</xbrli:startDate> <xbrli:endDate>2024-03-12</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-281">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-03-12_to_2024-03-12" format="ixt:datemonthdayyearen" id="ixv-282">March&#160;12, 2024</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-283">Akero Therapeutics, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-03-12_to_2024-03-12" format="ixt-sec:stateprovnameen" id="ixv-284">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-285">001-38944</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-286">81-5266573</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:33%"/>
<td style="vertical-align:bottom"/>
<td style="width:31%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom" colspan="3"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-287">601 Gateway Boulevard</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-288">Suite 350</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-289">South San Francisco</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-290">CA</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-291">94080</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-292">(650)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-293">487-6488</ix:nonNumeric></span></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-03-12_to_2024-03-12" format="ixt-sec:boolballotbox" id="ixv-294">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-03-12_to_2024-03-12" format="ixt-sec:boolballotbox" id="ixv-295">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-03-12_to_2024-03-12" format="ixt-sec:boolballotbox" id="ixv-296">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-03-12_to_2024-03-12" format="ixt-sec:boolballotbox" id="ixv-297">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-298">Common Stock, par value $0.0001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-299">AKRO</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-03-12_to_2024-03-12" format="ixt-sec:exchnameen" id="ixv-300">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167; <span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-03-12_to_2024-03-12" format="ixt-sec:boolballotbox" id="ixv-301">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;3.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the previously disclosed amendment to the Loan and Security Agreement, dated June&#160;15, 2022, as amended from time to time (&#8220;Loan Agreement&#8221;) with Hercules Capital, Inc., on March&#160;12, 2024, Akero Therapeutics, Inc. (the &#8220;Company&#8221;) issued a warrant to Hercules Private Credit Fund 1 L.P. (the &#8220;Warrant&#8221;) to purchase shares (the &#8220;Warrant Shares&#8221;) of the Company&#8217;s common stock, par value $0.0001 per share, with an exercise price of $8.17 per share. The number of Warrant Shares will not exceed 1.5% multiplied by the aggregate original amount of the term loan advances under the Loan Agreement, divided by the exercise price of the Warrant. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Warrant may be exercised through the earlier of (i)&#160;March 12, 2031 and (ii)&#160;the consummation of certain acquisition transactions involving the Company, as set forth in the Warrant. The number of Warrant Shares for which the Warrant is exercisable and the associated exercise price are subject to certain customary proportional adjustments for fundamental events, including stock splits and reverse stock splits, as set forth in the Warrant. Within six (6)&#160;months following the exercise of the Warrant, the Company shall prepare and file with the Securities and Exchange Commission a registration statement covering the resale of the Warrant Shares issued pursuant to such exercise notice for an offering to be made on a continuous basis and shall use best efforts to cause such registration statement to be declared effective. Notwithstanding the foregoing, the Company shall not be required to register the Warrant Shares in the event that the Warrant Shares issued pursuant to the exercise of the Warrant may be sold under Rule 144 or another similar exemption under the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preceding description of the Warrant does not purport to be complete and is qualified in its entirety by reference to the Warrant, which is filed as Exhibit 4.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and incorporated by reference it its entirety.</p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit</span><br/><span style="font-weight:bold">No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d691064dex41.htm">Warrant Agreement, by and between Akero Therapeutics, Inc. and Hercules Private Credit Fund 1 L.P., dated March&#160;12, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Date: March&#160;18, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">AKERO THERAPEUTICS, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Andrew Cheng</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Andrew Cheng, M.D., Ph.D.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">President and Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d691064dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;ACT&#148;), OR ANY
STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR, SUBJECT TO SECTION 11 HEREOF, AN OPINION OF COUNSEL (WHICH MAY BE COMPANY COUNSEL)
REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT, OR ANY APPLICABLE STATE SECURITIES LAWS. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">WARRANT AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To Purchase
Shares of the Common Stock of </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AKERO THERAPEUTICS, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of March&nbsp;12, 2024 (the &#147;<U>Effective Date</U>&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, AKERO THERAPEUTICS, INC., a Delaware corporation (the &#147;<U>Company</U>&#148;), has entered into a Loan and Security Agreement of
June&nbsp;15, 2022 (as amended and in effect from time to time, including by that certain First Amendment to Loan and Security Agreement dated as of June&nbsp;7, 2023 and that certain Second Amendment to Loan and Security agreement dated as of
February&nbsp;28, 2024, collectively, the &#147;<U>Loan Agreement</U>&#148;) with Hercules Capital, Inc., a Maryland corporation, in its capacity as administrative and collateral agent (&#147;<U>Agent</U>&#148;), HERCULES PRIVATE CREDIT FUND 1 L.P.
(the &#147;<U>Warrantholder</U>&#148;), and the lender parties thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Loan Agreement and as additional
consideration to the Warrantholder for, among other things, its agreements in the Loan Agreement, the Company has agreed to issue to the Warrantholder this Warrant Agreement, evidencing the right to purchase shares of the Company&#146;s Common Stock
(this &#147;<U>Warrant</U>&#148;, &#147;<U>Warrant Agreement</U>&#148;, or this &#147;<U>Agreement</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in
consideration of the Warrantholder having executed and delivered the Loan Agreement and provided the financial accommodations contemplated therein, and in consideration of the mutual covenants and agreements contained herein, the Company and the
Warrantholder agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SECTION 1. </B>GRANT OF THE RIGHT TO PURCHASE COMMON STOCK. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For value received, the Company hereby grants to the Warrantholder, and the Warrantholder is entitled, upon the terms and subject to the
conditions hereinafter set forth, to subscribe for and purchase, from the Company, up to the aggregate number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of Common Stock (as defined below) as determined pursuant
to Section&nbsp;1(b) below, at a purchase price per share equal to the Exercise Price (as defined below). The number and Exercise Price of such shares are subject to adjustment as provided in Section&nbsp;8. As used herein, the following terms shall
have the following meanings: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Act</U>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Charter</U>&#148; means the Company&#146;s Fourth Amended and Restated Certificate of Incorporation, as may be
amended and in effect from time to time. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Stock</U>&#148; means the Company&#146;s common stock,
$0.0001 par value per share, as presently constituted under the Charter, and any class and/or series of Company capital stock for or into which such common stock may be converted or exchanged in a reorganization, recapitalization or similar
transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exercise Price</U>&#148; means $8.17, subject to adjustment from time to time in accordance with
the provisions of this Warrant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liquid Sale</U>&#148; means the closing of a Merger Event in which the
consideration received by the Company and/or its shareholders, as applicable, consists solely of cash and/or Marketable Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Marketable Securities</U>&#148; in connection with a Merger Event means securities meeting all of the following
requirements: (i)&nbsp;the issuer thereof is then subject to the reporting requirements of Section&nbsp;13 or Section&nbsp;15(d) of the Securities Exchange Act of 1934, as amended (the &#147;<U>Exchange Act</U>&#148;), and is then current in its
filing of all required reports and other information under the Act and the Exchange Act; (ii)&nbsp;the class and series of shares or other security of the issuer that would be received by the Warrantholder in connection with the Merger Event were
the Warrantholder to exercise this Warrant on or prior to the closing thereof is then traded on a national securities exchange or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, and
(iii)&nbsp;following the closing of such Merger Event, the Warrantholder would not be restricted from publicly <FONT STYLE="white-space:nowrap">re-selling</FONT> all of the issuer&#146;s shares and/or other securities that would be received by the
Warrantholder in such Merger Event were the Warrantholder to exercise this Warrant in full on or prior to the closing of such Merger Event, except to the extent that any such restriction (x)&nbsp;arises solely under federal or state securities laws,
rules or regulations, and (y)&nbsp;does not extend beyond six (6)&nbsp;months from the closing of such Merger Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Merger Event</U>&#148; means any of the following: (i)&nbsp;a sale, lease or other transfer of all or substantially
all assets of the Company, (ii)&nbsp;any merger or consolidation involving the Company in which the Company is not the surviving entity or in which the outstanding shares of the Company&#146;s capital stock are otherwise converted into or exchanged
for shares of capital stock or other securities or property of another entity, or (iii)&nbsp;any sale by holders of the outstanding voting equity securities of the Company in a single transaction or series of related transactions of shares
constituting a majority of the outstanding combined voting power of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Price</U>&#148; means,
with respect to any exercise of this Warrant, an amount equal to the then-effective Exercise Price multiplied by the number of shares of Common Stock as to which this Warrant is then exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Warrant Coverage</U>&#148; means one and <FONT STYLE="white-space:nowrap">one-half</FONT> percent (1.50%)
<I>multiplied</I> by the aggregate original principal amount of Term Loan Advances made by Warrantholder (as defined in the Loan Agreement) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Number of Shares</U>. This Warrant shall be exercisable for a number of shares of Common Stock equal to the quotient of (i)&nbsp;the
Warrant Coverage, <I>divided</I> by (ii)&nbsp;the Exercise Price, subject to adjustment from time to time in accordance with the provisions of this Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SECTION 2. </B>TERM OF THE AGREEMENT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The term of this Agreement and the right to purchase Common Stock as granted herein shall commence on the Effective Date and, subject to
Section&nbsp;8(a) below, shall be exercisable until 5:00 p.m. (Eastern Time) on March [_], 2031. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SECTION 3. </B>EXERCISE OF THE PURCHASE RIGHTS.</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Exercise</U>. The purchase rights set forth in this Agreement are exercisable by the Warrantholder, in whole or in part, at any time, or
from time to time, prior to the expiration of the term set forth in Section&nbsp;2, by tendering to the Company at its principal office a notice of exercise in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;I</U> (the &#147;<U>Notice of
Exercise</U>&#148;), duly completed and executed. Promptly upon receipt of the Notice of Exercise and the payment of the Purchase Price in accordance with the terms set forth below, and in no event later than three (3)&nbsp;business days thereafter,
the Company or its transfer agent shall either (i)&nbsp;issue to the Warrantholder a certificate for the number of shares of Common Stock purchased or (ii)&nbsp;credit the same via book entry to the Warrantholder, and the Company shall execute the
acknowledgment of exercise in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;II</U> (the &#147;<U>Acknowledgment of Exercise</U>&#148;) indicating the number of shares which remain subject to future purchases under this Warrant, if any.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Purchase Price may be paid at the Warrantholder&#146;s election either (i)&nbsp;by cash or check, or (ii)&nbsp;by surrender of all or
a portion of the Warrant for shares of Common Stock to be exercised under this Agreement and, if applicable, an amended Agreement setting forth the remaining number of shares purchasable hereunder, as determined below (&#147;<U>Net
Issuance</U>&#148;). If the Warrantholder elects the Net Issuance method, the Company will issue shares of Common Stock in accordance with the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:9%; text-indent:4%">


<IMG SRC="g691064dsp06.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%" VALIGN="top" ALIGN="left">Where:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">X = the number of shares of Common Stock to be issued to the Warrantholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">Y = the number of shares of Common Stock requested to be exercised under this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">A = the then-current fair market value of one (1)&nbsp;share of Common Stock at the time of exercise of this Warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:7%; font-size:10pt; font-family:Times New Roman">B = the then-effective Exercise Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the above calculation, the current fair market value of shares of Common Stock shall mean with respect to each share of Common
Stock: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) at all times when the Common Stock is traded on a national securities exchange, inter-dealer quotation system or <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> bulletin board service, the average of the closing prices over a ten (10)&nbsp;day consecutive period ending three days before the day the current fair market
value of the securities is being determined; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) if the exercise is in connection with a Merger Event, the fair market value of a share
of Common Stock shall be deemed to be the per share value received by the holders of the outstanding shares of Common Stock pursuant to such Merger Event as determined in accordance with the definitive transaction documents executed among the
parties in connection therewith; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) in cases other than as described in the foregoing clauses (i)&nbsp;and (ii), the current fair
market value of a share of Common Stock shall be determined in good faith by the Company&#146;s Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Upon partial exercise
by either cash or Net Issuance, prior to the expiration or earlier termination hereof, the Company shall promptly issue an amended Agreement representing the remaining number of shares purchasable hereunder. All other terms and conditions of such
amended Agreement shall be identical to those contained herein, including, but not limited to the Effective Date hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Exercise Prior to Expiration</U>. To the extent this Warrant is not previously
exercised as to all shares of Common Stock subject hereto, and if the then-current fair market value of one share of Common Stock is greater than the Exercise Price then in effect, or, in the case of a Liquid Sale, where the value per share of
Common Stock (as determined as of the closing of such Liquid Sale in accordance with the definitive agreements executed by the parties in connection with such Merger Event) to be paid to the holders thereof is greater than the Exercise Price then in
effect, this Agreement shall be deemed automatically exercised on a Net Issuance basis pursuant to Section&nbsp;3(a) (even if not surrendered) as of immediately before its expiration determined in accordance with Section&nbsp;2. For purposes of such
automatic exercise, the fair market value of one share of Common Stock upon such expiration shall be determined pursuant to Section&nbsp;3(a). To the extent this Warrant or any portion hereof is deemed automatically exercised pursuant to this
Section&nbsp;3(b), the Company agrees to promptly notify the Warrantholder of the number of shares of Common Stock if any, the Warrantholder is to receive by reason of such automatic exercise, and to issue or cause its transfer agent to issue a
certificate or a book-entry credit to the Warrantholder evidencing such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SECTION 4. </B>RESERVATION OF SHARES.</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">During the term of this Agreement, the Company will at all times have authorized and reserved a sufficient number of shares of its Common Stock
to provide for the exercise of the rights to purchase Common Stock as provided for herein. If at any time during the term hereof the number of authorized but unissued shares of Common Stock shall not be sufficient to permit exercise of this Warrant
in full, the Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SECTION 5. </B>NO FRACTIONAL SHARES OR SCRIP. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Agreement, but in lieu of such
fractional shares the Company shall make a cash payment therefor in an amount equal to the product of (a)&nbsp;the Exercise Price then in effect multiplied by (b)&nbsp;the fraction of a share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SECTION 6. </B>NO RIGHTS AS SHAREHOLDER. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Without limitation of any provision hereof, the Warrantholder agrees that this Agreement does not entitle the Warrantholder to any voting
rights or other rights as a shareholder of the Company prior to the exercise of any of the purchase rights set forth in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SECTION 7. </B>WARRANTHOLDER REGISTRY. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company shall maintain a registry showing the name and address of the registered holder of this Agreement. The Warrantholder&#146;s initial
address, for purposes of such registry, is set forth in Section&nbsp;12(g) below. The Warrantholder may change such address by giving written notice of such changed address to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SECTION 8. </B>ADJUSTMENT RIGHTS.</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Exercise Price and the number of shares of Common Stock purchasable hereunder are subject to adjustment from time to time, as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Merger Event</U>. In connection with a Merger Event that is a Liquid Sale, this Warrant shall, on and after the closing thereof,
automatically and without further action on the part of any party or other person, represent the right to receive the consideration payable on or in respect of all shares of Common Stock that are issuable hereunder as of immediately prior to the
closing of such Merger Event less the Purchase Price for all such shares of Common Stock (such consideration to include both the consideration payable at the closing of such Merger Event and all deferred consideration payable thereafter, if any,
including, but not limited to, payments of amounts deposited at such closing into escrow and payments in the nature of earn-outs, milestone payments or other performance-based payments), and such Merger Event consideration shall be paid to the
Warrantholder as and when it is paid to the holders of the outstanding shares of Common Stock. In connection with a Merger Event that is not a Liquid Sale, the Company shall cause the successor or surviving entity to assume this Warrant and the
obligations of the Company hereunder on the closing thereof, and thereafter this Warrant shall be exercisable for the same number and type of securities or other property as the Warrantholder would have received in consideration for the shares of
Common Stock issuable hereunder had it exercised this Warrant in full as of immediately prior to such closing, at an aggregate Exercise Price no greater than the aggregate Exercise Price in effect as of immediately prior to such closing, and subject
to further adjustment from time to time in accordance with the provisions of this Warrant. The provisions of this Section&nbsp;8(a) shall similarly apply to successive Merger Events. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Reclassification of Shares</U>. Except for Merger Events subject to Section&nbsp;8(a), if the Company at any time shall, by combination,
reclassification, exchange or subdivision of securities or otherwise, change any of the securities as to which purchase rights under this Agreement exist into the same or a different number of securities of any other class or classes of securities,
this Agreement shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result of such change with respect to the securities which were subject to the purchase rights under this Agreement
immediately prior to such combination, reclassification, exchange, subdivision or other change. The provisions of this Section&nbsp;8(b) shall similarly apply to successive combination, reclassification, exchange, subdivision or other change. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Subdivision or Combination of Shares</U>. If the Company at any time shall combine or subdivide its Common Stock, (i)&nbsp;in the case
of a subdivision, the Exercise Price shall be proportionately decreased and the number of shares for which this Warrant is exercisable shall be proportionately increased, or (ii)&nbsp;in the case of a combination, the Exercise Price shall be
proportionately increased and the number of shares for which this Warrant is exercisable shall be proportionately decreased. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
<U>Dividends</U>. If the Company at any time while this Agreement is outstanding and unexpired shall: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) pay a dividend with respect to
the outstanding shares of Common Stock payable in additional shares of Common Stock, then the Exercise Price shall be adjusted, from and after the date of determination of shareholders entitled to receive such dividend, to that price determined by
multiplying the Exercise Price in effect immediately prior to such date of determination by a fraction (A)&nbsp;the numerator of which shall be the total number of shares of Common Stock outstanding immediately prior to such dividend or
distribution, and (B)&nbsp;the denominator of which shall be the total number of shares of Common Stock outstanding immediately after such dividend or distribution, and the number of shares of Common Stock for which this Warrant is exercisable shall
be proportionately increased; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) make any other dividend or distribution on or with respect to Common Stock, except any dividend or
distribution (A)&nbsp;in cash, or (B)&nbsp;specifically provided for in any other clause of this Section&nbsp;8, then, in each such case, provision shall be made by the Company such that the Warrantholder shall receive upon exercise or conversion of
this Warrant a proportionate share of any such dividend or distribution as though it were the holder of the Common Stock (or other stock for which the Common Stock is convertible) as of the record date fixed for the determination of the shareholders
of the Company entitled to receive such dividend or distribution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Notice of Certain Events</U>. If: (i)&nbsp;the Company shall declare any dividend or
distribution upon its outstanding Common Stock, payable in stock, cash, property or other securities (provided that the Warrantholder in its capacity as lender under the Loan Agreement consents to such dividend); (ii) the Company shall offer for
subscription pro rata to the holders of its Common Stock any additional shares of stock of any class or other rights; (iii)&nbsp;there shall be any Merger Event; or (iv)&nbsp;there shall be any voluntary dissolution, liquidation or winding up of the
Company; then, in connection with each such event, the Company shall give the Warrantholder notice thereof at the same time and in the same manner as it gives notice thereof to the holders of outstanding Common Stock. In addition, if at any time the
number of shares of Common Stock (or other securities of any other class or classes of securities of the Company for which this Warrant is then exercisable) outstanding is reduced such that the number of shares of Common Stock or other securities
issuable upon exercise of this Warrant shall exceed five percent (5%) of the then outstanding class of such securities, then, within three (3)&nbsp;business days of such event, the Company shall give the Warrantholder written notice thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 9. </B>REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Reservation of Common Stock</U>. The Company covenants and agrees that all shares of Common Stock that may be issued upon the exercise
of the rights represented by this Warrant will, upon issuance, be validly issued and outstanding, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and will be free of any taxes, liens, charges or encumbrances of any nature
whatsoever; provided, that the Common Stock issuable pursuant to this Agreement may be subject to restrictions on transfer under state and/or federal securities laws. The Company has made available to the Warrantholder true, correct and complete
copies of its Charter and bylaws currently in effect. The issuance of certificates or book-entry credit for shares of Common Stock upon exercise of this Warrant shall be made without charge to the Warrantholder for any issuance tax in respect
thereof, or other cost incurred by the Company in connection with such exercise and related issuance of shares of Common Stock. The Company further covenants and agrees that the Company will, at all times during the term hereof, have authorized and
reserved, free from preemptive rights, a sufficient number of shares of Common Stock to provide for the exercise of the rights represented by this Warrant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Due Authority</U>. The execution and delivery by the Company of this Agreement and the performance of all obligations of the Company
hereunder, including the issuance to the Warrantholder of the right to acquire the shares of Common Stock, have been duly authorized by all necessary corporate action on the part of the Company. This Agreement: (i)&nbsp;does not violate the Charter
or the Company&#146;s current bylaws; (ii)&nbsp;does not contravene any law or governmental rule, regulation or order applicable to the Company; and (iii)&nbsp;except as could not reasonably be expected to have a Material Adverse Effect (as defined
in the Loan Agreement), does not and will not contravene any provision of, or constitute a default under, any indenture, mortgage, contract or other instrument to which the Company is a party or by which it is bound. This Agreement constitutes a
legal, valid and binding agreement of the Company, enforceable in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or affecting creditors&#146; rights generally
(including, without limitation, fraudulent conveyance laws) and by general principles of equity, regardless of whether considered in a proceeding in equity or at law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Consents and Approvals</U>. No consent or approval of, giving of notice to, registration with, or taking of any other action in respect
of any state, federal or other governmental authority or agency is required with respect to the execution, delivery and performance by the Company of its obligations under this Agreement, except for the filing of notices pursuant to Regulation D
under the Act and any filing required by applicable state securities law, which filings will be effective by the time required thereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Exempt Transaction</U>. Subject to the accuracy of the Warrantholder&#146;s representations in Section&nbsp;10, the issuance of the
Common Stock upon exercise of this Agreement will constitute a transaction exempt from (i)&nbsp;the registration requirements of Section&nbsp;5 of the Act, in reliance upon Section&nbsp;4(a)(2) thereof, and (ii)&nbsp;the qualification requirements
of the applicable state securities laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Information Rights</U>. At all times (if any) prior to the earlier to occur of
(i)&nbsp;the date on which all shares of Common Stock issued on exercise of this Warrant have been sold, or (ii)&nbsp;the expiration or earlier termination of this Warrant, when the Company shall not be required to file reports pursuant to
Section&nbsp;13 or 15(d) of the Exchange Act or shall not have timely filed all such required reports, the Warrantholder shall be entitled to the information rights contained in Section&nbsp;7.1(b) of the Loan Agreement, provided that the
confidentiality provisions contained in Section&nbsp;11.13 of the Loan Agreement shall apply to any information received under this section, and in any such event Section&nbsp;7.1(b) and Section&nbsp;11.13 of the Loan Agreement is hereby
incorporated into this Agreement by this reference as though fully set forth herein, provided, however, that the Company shall not be required to deliver a Compliance Certificate once all Indebtedness (as defined in the Loan Agreement) owed by the
Company to the Warrantholder has been repaid. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Rule 144 Compliance</U>. The Company shall, at all times prior to the earlier to
occur of (i)&nbsp;the date of sale or other disposition by the Warrantholder of this Warrant or all shares of Common Stock issued on exercise of this Warrant, or (ii)&nbsp;the expiration or earlier termination of this Warrant if the Warrant has not
been exercised in full or in part on such date, use all commercially reasonable efforts to timely file all reports required under the Exchange Act and otherwise timely take all actions necessary to permit the Warrantholder to sell or otherwise
dispose of this Warrant and the shares of Common Stock issued on exercise hereof pursuant to Rule 144 promulgated under the Act (&#147;Rule 144&#148;), provided that the foregoing shall not apply in the event of a Merger Event following which the
successor or surviving entity is not subject to the reporting requirements of the Exchange Act. If the Warrantholder proposes to sell Common Stock issuable upon the exercise of this Agreement in compliance with Rule 144, then, upon the
Warrantholder&#146;s written request to the Company, the Company shall furnish to the Warrantholder, within five (5)&nbsp;business days after receipt of such request, a written statement confirming the Company&#146;s compliance with the filing and
other requirements of such Rule 144. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Registration of Shares</U>. Within six (6)&nbsp;months following the exercise of this Warrant,
the Company shall prepare and file with the Securities and Exchange Commission a registration statement covering the resale of the shares issued pursuant to such Exercise Notice for an offering to be made on a continuous basis and shall use best
efforts to cause such registration statement to be declared effective. Notwithstanding the foregoing, the Company shall not be required to comply with this Section&nbsp;9(g) in the event that the shares issued pursuant to the exercise of this
warrant may be sold under Rule 144 or another similar exemption under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 10. </B>REPRESENTATIONS AND
COVENANTS OF THE WARRANTHOLDER. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">This Agreement has been entered into by the Company in reliance upon the following representations and
covenants of the Warrantholder: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Investment Purpose</U>. This Warrant and the shares issued on exercise hereof will be acquired for
investment and not with a view to the sale or distribution of any part thereof in violation of applicable federal and state securities laws, and the Warrantholder has no present intention of selling or engaging in any public distribution of the same
except pursuant to a registration or exemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Private Issue</U>. The Warrantholder understands that (i)&nbsp;the Common Stock
issuable upon exercise of this Agreement is not, as of the Effective Date, registered under the Act or qualified under applicable state securities laws on the grounds that the issuance contemplated by this Agreement will be exempt from the
registration and qualifications requirements thereof, and (ii)&nbsp;the Company&#146;s reliance on exemption from such registration is predicated on the representations set forth in this Section&nbsp;10. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Financial Risk</U>. The Warrantholder has such knowledge and experience in financial
and business matters as to be capable of evaluating the merits and risks of its investment, and has the ability to bear the economic risks of its investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Accredited Investor</U>. The Warrantholder is an &#147;accredited investor&#148; within the meaning of Rule 501 of Regulation D
promulgated under the Act, as presently in effect (&#147;<U>Regulation D</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>No Short Sales</U>. The Warrantholder has not
at any time on or prior to the Effective Date engaged in any short sales or equivalent transactions in the Common Stock. Warrantholder agrees that at all times from and after the Effective Date and on or before the expiration or earlier termination
of this Warrant, it shall not engage in any short sales or equivalent transactions in the Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 11. </B>TRANSFERS.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to compliance with applicable federal and state securities laws, this Agreement and all rights hereunder are transferable, in
whole or in part, without charge to the holder hereof (except for transfer taxes) upon surrender of this Agreement properly endorsed, provided, that as long as no Event of Default (as defined in the Loan Agreement) has occurred and is continuing,
the holder hereof may not, without the Company&#146;s prior written consent, transfer this Agreement or any portion hereof, or any shares issued upon any exercise hereof, to any person or entity who directly competes with the Company (as reasonably
determined by Agent upon consultation with Company), it being acknowledged that in all cases, any transfer to an affiliate of the holder hereof shall be allowed. Each taker and holder of this Agreement, by taking or holding the same, consents and
agrees that this Agreement, when endorsed in blank, shall be deemed negotiable, and that the holder hereof, when this Agreement shall have been so endorsed and its transfer recorded on the Company&#146;s books, shall be treated by the Company and
all other persons dealing with this Agreement as the absolute owner hereof for any purpose and as the person entitled to exercise the rights represented by this Agreement. Subject to the first sentence of this Section&nbsp;11, the transfer of this
Agreement shall be recorded on the books of the Company upon receipt by the Company of a notice of transfer in the form attached hereto as Exhibit&nbsp;III (the &#147;<U>Transfer Notice</U>&#148;), at its principal offices and the payment to the
Company of all transfer taxes and other governmental charges imposed on such transfer. Until the Company receives such Transfer Notice, the Company may treat the registered owner hereof as the owner for all purposes. Notwithstanding anything herein
or in any legend to the contrary, the Company shall not require an opinion of counsel in connection with any sale, assignment or other transfer by the Warrantholder of this Warrant (or any portion hereof or any interest herein) or of any shares of
Common Stock issued upon any exercise hereof to an affiliate (as defined in Regulation D) of the Warrantholder, provided that such affiliate is an &#147;accredited investor&#148; as defined in Regulation D. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>SECTION 12. </B>MISCELLANEOUS. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Effective Date</U>. The provisions of this Agreement shall be construed and shall be given effect in all respects as if it had been
executed and delivered by the Company on the date hereof. This Agreement shall be binding upon any successors or assigns of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Remedies</U>. In the event of any default hereunder, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> party may proceed to
protect and enforce its rights either by suit in equity and/or by action at law, including but not limited to an action for damages as a result of any such default, and/or an action for specific performance for any default where the Warrantholder
will not have an adequate remedy at law and where damages will not be readily ascertainable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>No Impairment of Rights</U>. The
Company will not, by amendment of its Charter or through any other means, avoid or seek to avoid the observance or performance of any of the terms of this Agreement, but will at all times in good faith assist in the carrying out of all such terms
and in the taking of all such actions as may be reasonably necessary or appropriate in order to protect the rights of the Warrantholder against impairment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Additional Documents</U>. In the event the Company shall not be required to file
reports pursuant to Section&nbsp;13 or 15(d) of the Exchange Act, the Company agrees to supply such other documents as the Warrantholder may from time to time reasonably request to value this Warrant for Warrantholder&#146;s accounting or reporting
requirements and/or to evaluate whether to exercise (in cash or a net issuance basis) this Warrant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Attorneys&#146; Fees</U>. In
any litigation, arbitration or court proceeding between the Company and the Warrantholder relating hereto, the prevailing party shall be entitled to reasonable and documented attorneys&#146; fees and expenses and all costs of proceedings incurred in
enforcing this Agreement. For the purposes of this Section&nbsp;12(e), attorneys&#146; fees shall include without limitation fees incurred in connection with the following: (i)&nbsp;contempt proceedings; (ii)&nbsp;discovery; (iii) any motion,
proceeding or other activity of any kind in connection with an insolvency proceeding; (iv)&nbsp;garnishment, levy, and debtor and third party examinations; and (v)&nbsp;post-judgment motions and proceedings of any kind, including without limitation
any activity taken to collect or enforce any judgment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Severability</U>. In the event any one or more of the provisions of this
Agreement shall for any reason be held invalid, illegal or unenforceable, the remaining provisions of this Agreement shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable valid, legal and
enforceable provision, which comes closest to the intention of the parties underlying the invalid, illegal or unenforceable provision. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)
<U>Notices</U>. Except as otherwise provided herein, any notice, demand, request, consent, approval, declaration, service of process or other communication that is required, contemplated, or permitted under this Agreement or with respect to the
subject matter hereof shall be in writing, and shall be deemed to have been validly served, given, delivered, and received upon the earlier of: (i)&nbsp;personal delivery to the party to be notified, (ii)&nbsp;when sent by confirmed telex or
electronic transmission if sent during normal business hours of the recipient, if not, then on the next business day, (iii)&nbsp;five (5)&nbsp;days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or
(iv)&nbsp;one day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt, and shall be addressed to the party to be notified as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Warrantholder: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">HERCULES PRIVATE CREDIT FUND 1 L.P. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Legal Department </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Attention:
Chief Legal Officer, Cristy Barnes, and Briana Gironda </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">1 North B ST, Suite 2000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">San Mateo, CA. 94401 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Facsimile: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">650-473-9194</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">650-289-3060</FONT></FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>With a copy to</U><U> (which shall not constitute notice)</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">DLA PIPER LLP (US) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">401 B
Street, Suite 1700 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">San Diego, California 92101-4297 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Attn: Matt Schwartz, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Facsimile: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">858-638-5134</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">858-638-6834</FONT></FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Company: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">AKERO
THERAPEUTICS, INC. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Jonathan M. Young; William White </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">601 Gateway Blvd, Suite 350 South San Francisco, CA 94080 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">email: jonathan@akerotx.com, bill@akerotx.com, notices@akerotx.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>With a copy to (which shall not constitute notice)</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">GOODWIN PROCTER LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">100
Northern Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Boston, MA 02210 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Attention: Kevin D. Grumberg, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Facsimile: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">646-558-404</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-459-7147</FONT></FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">or to such other address as each party may designate for itself by like notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Entire Agreement; Amendments</U>. This Agreement constitutes the entire agreement and understanding of the parties hereto in respect of
the subject matter hereof, and supersedes and replaces in their entirety any prior proposals, term sheets, letters, negotiations or other documents or agreements, whether written or oral, with respect to the subject matter hereof. None of the terms
of this Agreement may be amended except by an instrument executed by each of the parties hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Headings</U>. The various headings
in this Agreement are inserted for convenience only and shall not affect the meaning or interpretation of this Agreement or any provisions hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Advice of Counsel</U>. Each of the parties represents to each other party hereto that it has discussed (or had an opportunity to
discuss) with its counsel this Agreement and, specifically, the provisions of Sections&nbsp;12(n), 12(o), 12(p), 12(q) and 12(r). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)
<U>No Strict Construction</U>. The parties hereto have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted
jointly by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>No Waiver</U>. No omission or delay by the Warrantholder at any time to enforce any right or remedy reserved to it, or to require
performance of any of the terms, covenants or provisions hereof by the Company at any time designated, shall be a waiver of any such right or remedy to which the Warrantholder is entitled, nor shall it in any way affect the right of the
Warrantholder to enforce such provisions thereafter during the term of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <U>Survival</U>. All agreements,
representations and warranties contained in this Agreement or in any document delivered pursuant hereto shall be for the benefit of the Warrantholder and shall survive the execution and delivery of this Agreement and the expiration or other
termination of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <U>Governing Law</U>. This Agreement has been negotiated and delivered to the Warrantholder in the
State of California, and shall be deemed to have been accepted by the Warrantholder in the State of California. Delivery of Common Stock to the Warrantholder by the Company under this Agreement is due in the State of California. This Agreement shall
be governed by, and construed and enforced in accordance with, the laws of the State of California, excluding conflict of laws principles that would cause the application of laws of any other jurisdiction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <U>Consent to Jurisdiction and Venue</U>. All judicial proceedings arising in or under or related to this Agreement may be brought in any
state or federal court of competent jurisdiction located in the State of California. By execution and delivery of this Agreement, each party hereto generally and unconditionally: (i)&nbsp;consents to personal jurisdiction in Santa Clara County,
State of California; (ii)&nbsp;waives any objection as to jurisdiction or venue in Santa Clara County, State of California; (iii)&nbsp;agrees not to assert any defense based on lack of jurisdiction or venue in the aforesaid courts; and
(iv)&nbsp;irrevocably agrees to be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
bound by any judgment rendered thereby in connection with this Agreement. Service of process on any party hereto in any action arising out of or relating to this Agreement shall be effective if
given in accordance with the requirements for notice set forth in Section&nbsp;12(g), and shall be deemed effective and received as set forth in Section&nbsp;12(g). Nothing herein shall affect the right to serve process in any other manner permitted
by law or shall limit the right of either party to bring proceedings in the courts of any other jurisdiction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <U>Mutual Waiver of Jury
Trial</U>. Because disputes arising in connection with complex financial transactions are most quickly and economically resolved by an experienced and expert person and the parties wish applicable state and federal laws to apply (rather than
arbitration rules), the parties desire that their disputes arising under or in connection with this Warrant be resolved by a judge applying such applicable laws. EACH OF THE COMPANY AND THE WARRANTHOLDER SPECIFICALLY WAIVES ANY RIGHT IT MAY HAVE TO
TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, CROSS-CLAIM, COUNTERCLAIM, THIRD PARTY CLAIM OR ANY OTHER CLAIM (COLLECTIVELY, &#147;CLAIMS&#148;) ASSERTED BY THE COMPANY AGAINST THE WARRANTHOLDER OR ITS ASSIGNEE OR BY THE WARRANTHOLDER OR ITS ASSIGNEE
AGAINST THE COMPANY RELATING TO THIS WARRANT. This waiver extends to all such Claims, including Claims that involve persons or entities other the Company and the Warrantholder; Claims that arise out of or are in any way connected to the relationship
between the Company and the Warrantholder, and any Claims for damages, breach of contract, specific performance, or any equitable or legal relief of any kind, arising out of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <U>Arbitration</U>. If the Mutual Waiver of Jury Trial set forth in Section&nbsp;12(p) is ineffective or unenforceable, the parties agree
that all Claims shall be submitted to binding arbitration in accordance with the commercial arbitration rules of JAMS (the &#147;Rules&#148;), such arbitration to occur before one arbitrator, which arbitrator shall be a retired California state
judge or a retired Federal court judge. Such proceeding shall be conducted in Santa Clara County, State of California, with California rules of evidence and discovery applicable to such arbitration. The decision of the arbitrator shall be binding on
the parties, and shall be final and nonappealable to the maximum extent permitted by law. Any judgment rendered by the arbitrator may be entered in a court of competent jurisdiction and enforced by the prevailing party as a final judgment of such
court. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <U><FONT STYLE="white-space:nowrap">Pre-arbitration</FONT> Relief</U>. In the event Claims are to be resolved by arbitration,
either party may seek from a court of competent jurisdiction identified in Section&nbsp;12(o), any prejudgment order, writ or other relief and have such prejudgment order, writ or other relief enforced to the fullest extent permitted by law
notwithstanding that all Claims are otherwise subject to resolution by binding arbitration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <U>Counterparts</U>. This Agreement and
any amendments, waivers, consents or supplements hereto may be executed in any number of counterparts (including by facsimile or electronic delivery (PDF), and by different parties hereto in separate counterparts, each of which when so delivered
shall be deemed an original, but all of which counterparts shall constitute but one and the same instrument. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <U>Specific
Performance</U>. The parties hereto hereby declare that it is impossible to measure in money the damages which will accrue to the Warrantholder by reason of the Company&#146;s failure to perform any of the obligations under this Agreement and agree
that the terms of this Agreement shall be specifically enforceable by the Warrantholder. If the Warrantholder institutes any action or proceeding to specifically enforce the provisions hereof, any person against whom such action or proceeding is
brought hereby waives the claim or defense therein that the Warrantholder has an adequate remedy at law, and such person shall not offer in any such action or proceeding the claim or defense that such remedy at law exists. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) <U>Lost, Stolen, Mutilated or Destroyed Warrant</U>. If this Warrant is lost, stolen, mutilated or destroyed, the Company may, on such
terms as to indemnity or otherwise as it may reasonably impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated or
destroyed. Any such new Warrant shall constitute an original contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <U>Legends</U>. To the extent required by applicable laws, this Warrant and the shares
of Common Stock issuable hereunder (and the securities issuable, directly or indirectly, upon conversion of such shares of Common Stock, if any) may be imprinted with a restricted securities legend in substantially the following form: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#147;ACT&#148;), OR ANY APPLICABLE STATE SECURITIES
LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION RELATED THERETO OR, SUBJECT TO SECTION 11 OF THE WARRANT AGREEMENT DATED MARCH&nbsp;12, 2024, BETWEEN THE COMPANY AND HERCULES PRIVATE
CREDIT FUND 1 L.P., AN OPINION OF COUNSEL (WHICH MAY BE COMPANY COUNSEL) REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACTOR ANY STATE SECURITIES LAWS.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Remainder of Page Intentionally Left Blank] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Warrant Agreement to be executed by
its officers thereunto duly authorized as of the Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">COMPANY:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AKERO THERAPEUTICS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jonathan Young</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Jonathan Young</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Operating Officer and Secretary</TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="76%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WARRANTHOLDER:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">HERCULES PRIVATE CREDIT FUND 1 L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Hercules Adviser LLC, its Investment Adviser</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Seth Meyer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print&nbsp;Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Seth Meyer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature page to Warrant Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT I </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NOTICE OF EXERCISE </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">To:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">AKERO THERAPEUTICS, INC. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The undersigned Warrantholder hereby elects to purchase [_______] shares of the Common Stock of AKERO
THERAPEUTICS, INC., pursuant to the terms of the Warrant Agreement dated March&nbsp;12, 2024 (the &#147;Warrant Agreement&#148;) between AKERO THERAPEUTICS, INC. and the Warrantholder, and [CASH PAYMENT: tenders herewith payment of the Purchase
Price in full, together with all applicable transfer taxes, if any.] [NET ISSUANCE: elects pursuant to Section&nbsp;3(a) of the Warrant Agreement to effect a Net Issuance.] </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Please issue a certificate or certificates or book-entry credit(s) representing said shares of Common Stock in
the name of the undersigned or in such other name as is specified below. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(Name)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(Address)</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">WARRANTHOLDER:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">HERCULES PRIVATE CREDIT FUND 1 L.P.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: Hercules Adviser LLC, its Investment Adviser</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print&nbsp;Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Seth Meyer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT II </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ACKNOWLEDGMENT OF EXERCISE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned, AKERO THERAPEUTICS, INC., hereby acknowledges receipt of the &#147;Notice of Exercise&#148; from HERCULES PRIVATE CREDIT FUND 1 L.P. to
purchase [____] shares of the Common Stock of AKERO THERAPEUTICS, INC. pursuant to the terms of the Warrant Agreement by and between AKERO THERAPEUTICS, INC. and HERCULES PRIVATE CREDIT FUND 1 L.P. dated March&nbsp;12, 2024 (the &#147;Warrant
Agreement&#148;), and further acknowledges that [______] shares remain subject to purchase under the terms of the Warrant Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">COMPANY:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">AKERO THERAPEUTICS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBIT III </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TRANSFER NOTICE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(To transfer or assign the
foregoing Agreement execute this form and supply required information. Do not use this form to purchase shares.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED, the foregoing
Agreement and all rights evidenced thereby are hereby transferred and assigned to </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Please Print)</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">whose address
is<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;
</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Dated:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Holder&#146;s Signature:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Holder&#146;s
Address:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Signature Guaranteed:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOTE: The signature to this Transfer Notice must correspond with the name as it appears on the face of the
Agreement, without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Agreement. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>akro-20240312.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/19/2024 12:19:51 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:akro="http://www.akerotx.com/20240312"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.akerotx.com/20240312"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="akro-20240312_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="akro-20240312_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>akro-20240312_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/19/2024 12:19:51 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>akro-20240312_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/19/2024 12:19:51 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="akro-20240312.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g691064dsp06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g691064dsp06.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1  (! @0$ P0'!00$  $"=P ! @,1
M! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_  !$( "0 5P,!$0 "$0$#$0'_V@ ,
M P$  A$#$0 _ /5O&OB;6/"NGG4K/08]2L8@#</]K,;PC/+%1&V5 Y)!S[<5
M/-:23T7?_,M1YEIOV_R"V\57VI:Y:V>D:=:7UBT$<US>K>L%@W<A0/+^8D<@
M9!QUVY&=>2SES:):>O\ 74RO[D6MWT_K^O(ZFH*"@#EI/$^IVGC:UT*^TFUM
M[2\#M;7OVUCYNWG:$\OA\<[2W3."<44_>YD]UK_7ZA/W4FMG^']=/T%M_%-X
M'U>\O].MK;1-.,@%ZEX9&FV]<)Y8Z<@_-U&!GK23]Q2>[V7?M]_0KEO/EC\_
M+_AOZUT-6SU"X71GU+5DBM%"&8Q@Y\F/&<,>Y]<<=N<9+G[B[M?GY?UJ33O4
M:MUV*GA+Q,GBG2I+O[))93PSO!-;2'+1LIXSTZ@@_C5.-HI]_P#AFODQ7]YK
MM^6Z8_Q9K=WX<\.7>KVMC%>"T0R2Q27!A^0#G!"-D^QQ]:C5R275I?>[%Q5[
MF?\ \)5J5CJFEV>MZ/!;)JC^5;SVEX;A1)M+!7#1H1D#J,_A56O)P6]F_N,^
M;W%/II^)J:/J\EW=7>FWR1Q:E9[3(L9RCHV=LBYYP<$8/0@CG@DT<>9>GS*>
MDK?,K^(M;>Q\K3K:QNY[N\Q&LB64LL$()QND95( 'IGZX'-1;G?(5?D7/_7]
M?TM3E_#)E\"^(I_"B6.HW6BRD36MW%82,D$C?>C=E7;C/S C@9(.,5K&7M%R
MO=;>:^?5?CZD2CROF[[^O?Y]OPL=+XF\,_V_+;O]GT27R01_Q,]*^V$9Q]T^
M8NWISUS6=M;E7TL1^&_"O]@WDL_V?08MZ;,Z;I'V1SSGEO,;(]L5=]+$-:IE
M#XIP?:/!DH@M+RXU&.5)+(V=O)))'*IR&!0';QGDX':H5O:1?GKZ;/\  U7P
MR3[?CT_$D\36BWGPPN(=*M9ECC@1XX'A:-RJ,&*E& 8$A2,$<YJINU2,WLI)
M_*_Z&=-.4'#JTU\VFOSZAXHU&35K?2])TL2F/4V21[L6,MQ;I%]X!BF!\Q &
M-PX))/J<K56STY=?FMO\_E;J)27LN;OI]^_^7_#,R+ ZOX:^)%VMXLM[;ZS
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M3/!WAG19H9]-T#3K6X@!$<T=L@D7(P?GQNZ$CKWIMW VZ0!0 4 % !0 4 %
M'+>-M0@CM+72)5N'74)-LZVUO).X@7F3Y8U9L'A,XXWU-E*5GLM7^GX_@F5=
MQBY+?9?UY*_SL9OPQU!1INH>'\3J='N#' +B%XG-NV6B)5P&'&1R/X:UNYTX
MS>^S]5_FK,S=HU)16SU7SW^YW.[J"@H * "@ H * "@ H * ,S^P-/&OG6]L
M_P!O\ORMWVJ79M]/+W;,=^G7GK1'W;VZA+WK7Z?U_7R[$*>%=)C\2/X@6*X&
DINH1I/M<VTJ!@*4W;<<],8SSUIQ?(FEU"7O6OT-FD 4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140351993607968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 12, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001744659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 12,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Akero Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-5266573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">601 Gateway Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">487-6488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AKRO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ W8-R6)>*NQS
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M=1,92L88!.R '<(Y_<Z[5ITPX1X=\G>A^[<#K3P&]'@!6^A<JU3'\TLDO,3
MQFU+BLX5>C(,=D",Y1]XVXG\-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=
MR_$)'0.M#,,SQ;;!<.AHQ$5V9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D
M&IND53 >"CVN*!.L>@PL(:EU&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&
ML&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%     @
MW8-R6"0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L
M<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>+7_O
MR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!
MV#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6
MHJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0
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M&G_FB^$_7G\!4$L! A0#%     @ W8-R6 =!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #=@W)8T"0E
M=^\    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " #=@W)8F5R<(Q &  "<)P  $P              @ '- 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -V#<E@<4;N*;P0  $(1
M   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " #=@W)8GZ ;\+$"  #B#   #0              @ &S#
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -V#<EB7BKL<P    !,"   +
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4!08     "0 ) #X"   3%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d691064d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>akro-20240312.xsd</File>
    <File>akro-20240312_lab.xml</File>
    <File>akro-20240312_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d691064d8k.htm">d691064d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d691064d8k.htm": {
   "nsprefix": "akro",
   "nsuri": "http://www.akerotx.com/20240312",
   "dts": {
    "schema": {
     "local": [
      "akro-20240312.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "akro-20240312_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "akro-20240312_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d691064d8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-03-12_to_2024-03-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d691064d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-03-12_to_2024-03-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d691064d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.akerotx.com//20240312/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-24-070191-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-070191-xbrl.zip
M4$L#!!0    ( -V#<EBQ:TI!/P,  $H+   1    86MR;RTR,#(T,#,Q,BYX
M<V2]5M]OVS80?B_0_^&FIPVH1,MN!EB(4Z1+ P1(T\)-A[T5M'1VB%"D1E*)
M_=_W2$F.[,2>DPSUBVG>?7??_:2//RQ+"7=HK-!J$J7)( )4N2Z$6DRBVL;<
MYD)$'T[>OCG^+8[A[/SB"F*X<:ZR&6/W]_=),1?*:ED[LF"37)<,XKC3_^OZ
M._S=6,]@BA*Y12BY=6C@8RUDD0T'PU$Z2(?)L \SR+T]*+C##$8L'3-2? _I
M,$O'V5$*IY_A4S"CX%J4V,?J:F7$XL;![_D?$%!G6BF4$E=P+A17N> 2OG64
MW\&%RA,XE1*F'F:)IT5SAT726EW:(K/Y#9;\[1L 2IBRF2*3=3F)?";:1"QG
M1B;:+%CA#'.K"ADIQ:2%1N11#_K?N$<8JH27V#5PSNTL@#J)S\^HA^"W1F^X
MX;=HM%N&"OFL#$;IL*=?H%BK!T86\V2A[Q@)MFU[N7@ZAN%@,&+4$([2C#V(
M%.IV#\*+9]0;?2>/(/>C $C'XS$+TBU*A=N,H+5^Q!IAT.;.&3&K'9YK4Y[A
MG->24+7ZM^92S 4608L:M43E-G0V-1PW"W17O$1;\1R?DVEJIZ?"(J8I^^?S
MY;?0:=&)!P"$YA-EI8V#I@<O=1YF8T\V_:^X*T+LK^)T&(_2A(Q%H)XDO:."
MP%Y-I*OMBXBL&^-@(G97 _M#[ ^[O#_=]B_.P/8X^_C'/O[TSX/B?[0._@<F
M6EV]EDQOI[V\)HJ+O%E9S?'PNCP@7]6;W5+P>3C:ZWA[B[1>@T^NE';!49\)
MKRJAYKJ]HDO?Q%G7R5.<0]A>&3>YT1+W[SA6&5VA<8)6_,,P- 9N#,XGD=_T
M<;=G?D@^2VC/="J/'&R.EQ<S@J"\?*#789UP'GSIQ>#E]%9RN3;MVV$26<J[
M[(WG+PZW,OC<< EB:;F'LNV.^FM/Z]G!>S_7I '^\'UZL?-Y6+\/S/&E5KI<
M-1S/=%[[%ZC[/E7%)T7,5A?46*8,K"(0])!,2?W'0>IKCAW+ NFOFPC=FP[\
MA_[9=1;Z1ZX*:,Q!S]XQVS:R;;^V6'Q1)^&<<YG7<IWS%MQJ[ -N5^MPY .S
MW;CVMJM7-\5L>XS;F_ZX-U?-NJ&?/P%02P,$%     @ W8-R6+J54%I[!@
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M<;Y_S.G]OST=)'#3_^>U,@ZG^'WNO/MGV:P;B/JEW/AVSEG#^^7[>1T!66F
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M,#SDL_52WG&MMO2O7,EWT>P7CZ@]_P-02P,$%     @ W8-R6*OC T/!!
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M:);/. 0DVNC.3.'0$::H?8,%)0$L#(@,,A?&=N"_Z?#%BNEZX,JTE !W[A;
M-*2-B7R.,F"VQ:;]8K/3+#*#/S[U)$X7W9$VBJ:FG %N1XI4KI#3$?!.4"&*
MOJ:A+G8[LUV_YG1RJ*$M4=G0)K6N2DLAJ4I=./RZ@ZP\ZM<UHAE5&"],ISC!
M.?58R;PR.>O69*51J3)0G2!)&GBV!V2FF%0(&TL",M?H1<ZL:\KM,1B#4I#=
MK+J]UV5A$6=.#47-KXQG-1I[V -%>1_'^^(W6!Z*:8^XOKCV&';8FMY@<_/)
M$--X**VRIKZ0RCX=FS/OV#P >L7I/KO$JZ)C(6V)ZT]KR[##]J,WV%9SPR-,
MF.VH,'<T/YA:M;:^T*K].F8_><8,%P12S:0J4CO #$-/SG&*7_9D=B3"SX2J
M.]'/V'> ?_8,\#7C<#?/1Z".H[FIJSNZ3:^.4\LS3D.ZZ&>8!C9FJT7I6Z#M
M#5)W@GN-KW$V3SS#V<TR3+)>?^ "&>+C4%8&J#O&2M,.8>P]PN1+$28^(DS^
M1>C;VGS=BQY^O5=#^2+>!'!3[@F^3<L.GC\K]%)7BDNQ>_6@Y#.SF[YO(;@3
MPQ.,.[X=RU,_63Y(;2C_B\V.7UU41_"$XY9K1]&??1D[GW05T&.XE37U)57V
MZ=CXL_EB[V+QAZD41Z[S=G7U9;3KU7'R9\/E#_1G0/1DGL_%>IFC#X6U1UQ?
M8GL,.VS^;*,,)&<I,TQ,;O'/6#%K[3!F5<KZ JMRZVCYLYGRH, ..<"KI>(^
MB+T-K>['X\.GQ=<BU)?>:Z[7%$_]V4/9ZDU?ZSFH+V=9$<<;HA7>'5=_-E8&
MD,ZMQ3@9#9GA!U]*[NKJRVW7J^/DS^[)4%'[G-Q@F8_DP7]W6Z+Z$MHRZO#X
MLS_BAMC5(IU2,8%C;K=6:^L+J]JO8^;;/LA5#FJ"8^]7)5_,%.?W&15'/C*T
M)T1]";YJVX'\'[9"SJ.=U-Q@@7WL=77$OMF'.+'D;U!+ P04    " #=@W)8
MDNX5(Z 1  "];   #@   &0V.3$P-C1D.&LN:'1M[1UK4R*Y]KN_(L7L[&J5
M/!I0 1UNN0PSRYT9M<2IW;I?MD)WD.PTG=XD+7!__3TGZ6Z:EZ"@SNS5*H7N
MO$[.^YP\//O7>.B3.R85%\&[7YQ"Z1?" E=X/+A]]\MYM]7I_/*OYM[90$,U
MJ!JHAL?XN]Q Z[!1+(Y[TB\HYA9NQ5T1"HKE4KF2BRM&*J\G(5-I[3Y5O8*0
MM\6D9*9Z(((@&J:51Z-1P72/#3PMB]BB")7R4(M)[B;MQCX/OLTT&U5,(Z=>
MKQ=-:5)UH68Z0+E4JA2QN$<52ZK3;U+,5*??F!1Z7'#%$$&OEBI..05#\65
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M9'*"! J**TNFY^+*SW:<>5&E+>4P\(N>AA/LVALE]IYD[[CNE(ZK'AM7G<)
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M6[XFLGP!+WD$KLMAM)U9I)J\3,6EY;.<B!0+ D5Z7EV62:,"Q[-EL"P60,-
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MXY]T^6V<"E;7NW@$+LQ!SI;V)N!4FU.D[G LKI6#5#L;:*#R(]&]0(O3D3%
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MD[KDVI3+4JV):W@F46%C=@0I6?$&]?"<GGW.37A<ED27.@ML-[)J!'([L%2
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M4*-RD=>!6XG !V@[N&Q82M87G!FX3M=,UV>!#\!4QDAKQ2RS7F\A/0K-@3#
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M]6+U.:@16^M_+M5H<V-S=>OYZ]67&ULO'ULU<CHJ22Q+&K:'.3<LL#BF882
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M-ND4]),8_0LVPX6_$?]B<HX[;DJKZ.H\U$)3"/&*9*VWW@/9E629.[N#C<=
M*-#:6LS\X=5G\10-C6MFB#&WQI_EY4Z:=Z!0GK/;5?>#"VJSN$TI(\HUYQ)]
MF:2!8*G*:.1G"95DUZ-[M_[-GF?+)'3K=EJP6C:JB(LNEE[ A6,4$E;XU6?T
M:"Y$BB4&@"2/6K;$R-)\=B(I&2B-=',\A[7-D>2VG8&J,$*:3_-CSZU$@W4
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M[GR!+_?Z'_??_Q]02P$"% ,4    " #=@W)8L6M*03\#  !*"P  $0
M        @ $     86MR;RTR,#(T,#,Q,BYX<V102P$"% ,4    " #=@W)8
MNI506GL&  "Z1@  %0              @ %N P  86MR;RTR,#(T,#,Q,E]L
M86(N>&UL4$L! A0#%     @ W8-R6*OC T/!!   /BP  !4
M ( !' H  &%K<F\M,C R-# S,3)?<')E+GAM;%!+ 0(4 Q0    ( -V#<EB2
M[A4CH!$  +UL   .              "  1 /  !D-CDQ,#8T9#AK+FAT;5!+
M 0(4 Q0    ( -V#<E@!Q2 Z^$$  *I) 0 0              "  =P@  !D
E-CDQ,#8T9&5X-#$N:'1M4$L%!@     %  4 /P$   )C      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d691064d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="akro-20240312.xsd" xlink:type="simple"/>
    <context id="duration_2024-03-12_to_2024-03-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001744659</identifier>
        </entity>
        <period>
            <startDate>2024-03-12</startDate>
            <endDate>2024-03-12</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-270">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-03-12_to_2024-03-12"
      id="Hidden_dei_EntityCentralIndexKey">0001744659</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-281">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-282">2024-03-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-283">Akero Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-284">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-285">001-38944</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-286">81-5266573</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-287">601 Gateway Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-288">Suite 350</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-289">South San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-290">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-291">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-292">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-293">487-6488</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-294">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-295">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-296">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-297">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-298">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-299">AKRO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-300">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-03-12_to_2024-03-12" id="ixv-301">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
